SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $249,000 | +87.2% | 15,957 | +38.1% | 0.00% | – |
| Q4 2018 | $133,000 | -84.6% | 11,551 | -77.3% | 0.00% | -100.0% |
| Q3 2018 | $861,000 | +8.7% | 50,782 | -8.9% | 0.00% | 0.0% |
| Q2 2018 | $792,000 | -36.6% | 55,740 | -15.2% | 0.00% | 0.0% |
| Q1 2018 | $1,249,000 | +35.0% | 65,736 | +16.6% | 0.00% | 0.0% |
| Q4 2017 | $925,000 | +16.5% | 56,372 | +6.6% | 0.00% | 0.0% |
| Q3 2017 | $794,000 | +32.1% | 52,901 | -5.1% | 0.00% | -50.0% |
| Q3 2014 | $601,000 | -29.4% | 55,742 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $851,000 | -15.6% | 55,742 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $1,008,000 | +31.8% | 55,742 | +1.3% | 0.00% | +50.0% |
| Q4 2013 | $765,000 | +10.1% | 55,042 | -17.0% | 0.00% | 0.0% |
| Q3 2013 | $695,000 | +34.2% | 66,300 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $518,000 | +402.9% | 66,300 | +287.7% | 0.00% | – |
| Q4 2012 | $103,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |